A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer
Titel:
A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer
Auteur:
Rustin, G. Reed, N. Jayson, G.C. Ledermann, J.A. Adams, M. Perren, T. Poole, C. Lind, M. Persic, M. Essapen, S. Gore, M. Calvert, H. Stredder, C. Wagner, A. Giurescu, M. Kaye, S.